Literature DB >> 33435711

Diabetic Retinopathy Screening Using Artificial Intelligence and Handheld Smartphone-Based Retinal Camera.

Fernando Korn Malerbi1,2, Rafael Ernane Andrade1,3, Paulo Henrique Morales1,2, José Augusto Stuchi4, Diego Lencione4, Jean Vitor de Paulo4, Mayana Pereira Carvalho5, Fabrícia Silva Nunes5, Roseanne Montargil Rocha5, Daniel A Ferraz2,6, Rubens Belfort1,2.   

Abstract

BACKGROUND: Portable retinal cameras and deep learning (DL) algorithms are novel tools adopted by diabetic retinopathy (DR) screening programs. Our objective is to evaluate the diagnostic accuracy of a DL algorithm and the performance of portable handheld retinal cameras in the detection of DR in a large and heterogenous type 2 diabetes population in a real-world, high burden setting.
METHOD: Participants underwent fundus photographs of both eyes with a portable retinal camera (Phelcom Eyer). Classification of DR was performed by human reading and a DL algorithm (PhelcomNet), consisting of a convolutional neural network trained on a dataset of fundus images captured exclusively with the portable device; both methods were compared. We calculated the area under the curve (AUC), sensitivity, and specificity for more than mild DR.
RESULTS: A total of 824 individuals with type 2 diabetes were enrolled at Itabuna Diabetes Campaign, a subset of 679 (82.4%) of whom could be fully assessed. The algorithm sensitivity/specificity was 97.8 % (95% CI 96.7-98.9)/61.4 % (95% CI 57.7-65.1); AUC was 0·89. All false negative cases were classified as moderate non-proliferative diabetic retinopathy (NPDR) by human grading.
CONCLUSIONS: The DL algorithm reached a good diagnostic accuracy for more than mild DR in a real-world, high burden setting. The performance of the handheld portable retinal camera was adequate, with over 80% of individuals presenting with images of sufficient quality. Portable devices and artificial intelligence tools may increase coverage of DR screening programs.

Entities:  

Keywords:  Covid-19; artificial intelligence; diabetic retinopathy; mobile healthcare; point-of-care; screening; telemedicine

Mesh:

Year:  2021        PMID: 33435711      PMCID: PMC9294565          DOI: 10.1177/1932296820985567

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  27 in total

1.  A more human approach to artificial intelligence.

Authors:  Michael Segal
Journal:  Nature       Date:  2019-07       Impact factor: 49.962

2.  World Diabetes Day 2012--expanding the circle of influence.

Authors:  Isabella Platon
Journal:  Diabetes Res Clin Pract       Date:  2012-08-21       Impact factor: 5.602

3.  The feasibility of smartphone based retinal photography for diabetic retinopathy screening among Brazilian Xavante Indians.

Authors:  Fernando Korn Malerbi; Amaury Lelis Dal Fabbro; João Paulo Botelho Vieira Filho; Laercio Joel Franco
Journal:  Diabetes Res Clin Pract       Date:  2020-08-21       Impact factor: 5.602

4.  Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.

Authors:  Yuchen Xie; Quang D Nguyen; Haslina Hamzah; Gilbert Lim; Valentina Bellemo; Dinesh V Gunasekeran; Michelle Y T Yip; Xin Qi Lee; Wynne Hsu; Mong Li Lee; Colin S Tan; Hon Tym Wong; Ecosse L Lamoureux; Gavin S W Tan; Tien Y Wong; Eric A Finkelstein; Daniel S W Ting
Journal:  Lancet Digit Health       Date:  2020-04-23

Review 5.  Telehealth practice recommendations for diabetic retinopathy, second edition.

Authors:  Helen K Li; Mark Horton; Sven-Erik Bursell; Jerry Cavallerano; Ingrid Zimmer-Galler; Mathew Tennant; Michael Abramoff; Edward Chaum; Debra Cabrera Debuc; Tom Leonard-Martin; Marc Winchester; Mary G Lawrence; Wendell Bauman; W Kelly Gardner; Lloyd Hildebran; Jay Federman
Journal:  Telemed J E Health       Date:  2011-10-04       Impact factor: 3.536

Review 6.  Screening for diabetic retinopathy: new perspectives and challenges.

Authors:  Stela Vujosevic; Stephen J Aldington; Paolo Silva; Cristina Hernández; Peter Scanlon; Tunde Peto; Rafael Simó
Journal:  Lancet Diabetes Endocrinol       Date:  2020-02-27       Impact factor: 32.069

7.  Predictors of Photographic Quality with a Handheld Nonmydriatic Fundus Camera Used for Screening of Vision-Threatening Diabetic Retinopathy.

Authors:  Jose R Davila; Sabyasachi S Sengupta; Leslie M Niziol; Manavi D Sindal; Cagri G Besirli; Swati Upadhyaya; Maria A Woodward; Rengaraj Venkatesh; Alan L Robin; Joseph Grubbs; Paula Anne Newman-Casey
Journal:  Ophthalmologica       Date:  2017-07-05       Impact factor: 3.250

Review 8.  The English National Screening Programme for diabetic retinopathy 2003-2016.

Authors:  Peter H Scanlon
Journal:  Acta Diabetol       Date:  2017-02-22       Impact factor: 4.280

9.  Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices.

Authors:  Michael D Abràmoff; Philip T Lavin; Michele Birch; Nilay Shah; James C Folk
Journal:  NPJ Digit Med       Date:  2018-08-28

10.  Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.

Authors:  Ângela J Ben; Jeruza L Neyeloff; Camila F de Souza; Ana Paula O Rosses; Aline L de Araujo; Adriana Szortika; Franciele Locatelli; Gabriela de Carvalho; Cristina R Neumann
Journal:  Appl Health Econ Health Policy       Date:  2020-02       Impact factor: 2.561

View more
  4 in total

1.  Feasibility of telemedicine program using a hand-held nonmydriatic retinal camera in Panama.

Authors:  Alexander S Himstead; Janani Prasad; Sean Melucci; Kevin M Gustafson; Paul E Israelsen; Andrew Browne
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

Review 2.  The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment.

Authors:  Ishrat Ahmed; T Y Alvin Liu
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 4.810

3.  Diabetic Macular Edema Screened by Handheld Smartphone-based Retinal Camera and Artificial Intelligence.

Authors:  Fernando Korn Malerbi; Giovana Mendes; Nathan Barboza; Paulo Henrique Morales; Roseanne Montargil; Rafael Ernane Andrade
Journal:  J Med Syst       Date:  2021-12-11       Impact factor: 4.460

4.  Feasibility of screening for diabetic retinopathy using artificial intelligence, Brazil.

Authors:  Fernando Korn Malerbi; Gustavo Barreto Melo
Journal:  Bull World Health Organ       Date:  2022-08-22       Impact factor: 13.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.